ATE254913T1 - Diacerein zur behandlung von psoriasis - Google Patents

Diacerein zur behandlung von psoriasis

Info

Publication number
ATE254913T1
ATE254913T1 AT01900029T AT01900029T ATE254913T1 AT E254913 T1 ATE254913 T1 AT E254913T1 AT 01900029 T AT01900029 T AT 01900029T AT 01900029 T AT01900029 T AT 01900029T AT E254913 T1 ATE254913 T1 AT E254913T1
Authority
AT
Austria
Prior art keywords
diacerein
psoriasis
treatment
Prior art date
Application number
AT01900029T
Other languages
English (en)
Inventor
Napoli Guido Di
Original Assignee
Medidom Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medidom Lab filed Critical Medidom Lab
Application granted granted Critical
Publication of ATE254913T1 publication Critical patent/ATE254913T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT01900029T 2000-01-12 2001-01-08 Diacerein zur behandlung von psoriasis ATE254913T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH532000 2000-01-12
PCT/IB2001/000005 WO2001051044A2 (en) 2000-01-12 2001-01-08 Substances for use in treating psoriasis

Publications (1)

Publication Number Publication Date
ATE254913T1 true ATE254913T1 (de) 2003-12-15

Family

ID=4291590

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01900029T ATE254913T1 (de) 2000-01-12 2001-01-08 Diacerein zur behandlung von psoriasis

Country Status (22)

Country Link
US (2) US6844365B2 (de)
EP (1) EP1248608B1 (de)
JP (1) JP4912554B2 (de)
CN (1) CN1187045C (de)
AR (1) AR026801A1 (de)
AT (1) ATE254913T1 (de)
AU (1) AU776324B2 (de)
BR (2) BRPI0107493B8 (de)
CA (1) CA2396111C (de)
CZ (1) CZ301129B6 (de)
DE (1) DE60101309T2 (de)
DK (1) DK1248608T3 (de)
ES (1) ES2210120T3 (de)
IL (2) IL150390A0 (de)
MX (1) MXPA02006610A (de)
PL (1) PL212010B1 (de)
PT (1) PT1248608E (de)
RU (1) RU2266740C2 (de)
SK (1) SK286589B6 (de)
TR (1) TR200400228T4 (de)
WO (1) WO2001051044A2 (de)
ZA (1) ZA200205148B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020128317A1 (en) * 2001-01-23 2002-09-12 Laboratories Negma Treatment of pathological conditions characterized by an increased IL-1 level
CN1321636C (zh) * 2002-12-30 2007-06-20 北京大学第一医院 大黄酸在抑制血管生成中的应用
NZ608319A (en) 2005-05-16 2014-08-29 Abbvie Biotechnology Ltd Use of tnf inhibitor for treatment of erosive polyarthritis
EP2007426A4 (de) * 2006-04-10 2010-06-16 Abbott Biotech Ltd Anwendungen und zusammensetzungen zur behandlung von psoriasis-arthritis
US20080085912A1 (en) * 2006-10-06 2008-04-10 Unitech Pharmaceuticals, Inc. Isoxazole derivatives and methods of treating diseases
EP2060562A1 (de) 2007-11-16 2009-05-20 Laboratoire Medidom S.A. Dioxoanthracen-Sulfonat-Derivate
WO2009133430A1 (en) * 2008-04-30 2009-11-05 Wockhardt Research Centre Topical compositions of rhein or diacerein
CN101537002B (zh) * 2009-04-24 2012-02-29 安士制药（中山）有限公司 具有优良溶出性能的双醋瑞因组合物及其制备和用途
PT2555618E (pt) * 2010-04-08 2016-03-08 Twi Biotechnology Inc Métodos de utilização da diacereína como terapia adjuvante para a diabetes
WO2017123672A1 (en) * 2016-01-12 2017-07-20 Lawrence Chan Combination treatment for inflammatory diseases
CN106236729A (zh) * 2016-07-31 2016-12-21 合肥远志医药科技开发有限公司 一种双醋瑞因胶囊制剂及其制备方法
CN106692109A (zh) * 2017-01-02 2017-05-24 佛山市腾瑞医药科技有限公司 一种微孔膜控释包衣双醋瑞因微丸及其制备方法
TWI794200B (zh) * 2017-01-19 2023-03-01 安成生物科技股份有限公司 預防或治療免疫發炎性皮膚疾病的方法及醫藥組合物
CN106619555A (zh) * 2017-02-14 2017-05-10 佛山市腾瑞医药科技有限公司 一种双醋瑞因速释微丸制剂、制备方法
CN106667954A (zh) * 2017-02-14 2017-05-17 佛山市腾瑞医药科技有限公司 一种双醋瑞因软胶囊制剂及其制备工艺
CN106727360A (zh) * 2017-02-16 2017-05-31 佛山市腾瑞医药科技有限公司 一种双醋瑞因固体分散体制剂及其制备方法
AU2019245521A1 (en) * 2018-03-29 2020-11-12 S.I.S Shulov Innovative Science Ltd. Pharmaceutical compositions for inhibiting inflammatory cytokines
WO2021011538A1 (en) * 2019-07-15 2021-01-21 R.P. Scherer Technologies, Llc Capsule dosage forms, methods of preparation and methods of use thereof
CN112755013A (zh) * 2021-02-22 2021-05-07 北京市中医研究所 大黄酸作为s100a8的抑制剂在炎症性疾病中的制药应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA761627B (en) 1976-03-16 1978-01-25 C Friedmann Improvements in or relating to the treatment of arthritis
IT1197316B (it) * 1986-10-01 1988-11-30 Proter Spa Formulazione galenica ad uso orale di derivati della reina a lento rilascio per impiego terapeutico
IT1264545B1 (it) 1993-07-30 1996-10-02 Medidom Lab Procedimento per la preparazione della diacereina
IT1282381B1 (it) 1996-04-29 1998-03-20 Trans Bussan S A Nuove formulazioni di diacereina, ottenute per inclusione del principio attivo in idrogel polisaccaridi
IT1283771B1 (it) 1996-07-31 1998-04-30 Medidom Lab Procedimento per la preparazione di derivati della reina
IT1283772B1 (it) 1996-07-31 1998-04-30 Medidom Lab Procedimento per la preparazione di reina e diacereina
JP4049406B2 (ja) * 1996-10-15 2008-02-20 正規 小菅 津液改善剤及びそれを含有する経口投与用組成物
JP4018764B2 (ja) * 1996-10-18 2007-12-05 正規 小菅 津液改善用皮膚外用剤
JPH10129556A (ja) 1996-10-28 1998-05-19 Fumiaki Mori 盗難防止自転車
FR2757397B1 (fr) * 1996-12-23 1999-03-05 Mazal Pharma Composition pharmaceutique a base de rheine ou de diacerheine a biodisponibilite amelioree
IT1297038B1 (it) 1997-12-30 1999-08-03 Medidom Lab Procedimento per la preparazione di reina e suoi diacilderivati

Also Published As

Publication number Publication date
SK9912002A3 (en) 2003-02-04
BR0107493A (pt) 2002-10-08
WO2001051044A2 (en) 2001-07-19
EP1248608A2 (de) 2002-10-16
WO2001051044A3 (en) 2002-03-28
DK1248608T3 (da) 2004-04-05
DE60101309D1 (de) 2004-01-08
JP2003519653A (ja) 2003-06-24
MXPA02006610A (es) 2004-09-10
ZA200205148B (en) 2003-06-26
RU2266740C2 (ru) 2005-12-27
SK286589B6 (sk) 2009-01-07
PL356784A1 (en) 2004-07-12
DE60101309T2 (de) 2004-09-16
US20050004045A1 (en) 2005-01-06
AU776324B2 (en) 2004-09-02
CN1187045C (zh) 2005-02-02
PL212010B1 (pl) 2012-07-31
CA2396111C (en) 2008-12-02
US6844365B2 (en) 2005-01-18
IL150390A (en) 2007-07-24
EP1248608B1 (de) 2003-11-26
AU2213201A (en) 2001-07-24
TR200400228T4 (tr) 2004-02-23
JP4912554B2 (ja) 2012-04-11
PT1248608E (pt) 2004-04-30
CZ20022382A3 (cs) 2002-11-13
US20020143057A1 (en) 2002-10-03
IL150390A0 (en) 2002-12-01
CZ301129B6 (cs) 2009-11-11
AR026801A1 (es) 2003-02-26
CA2396111A1 (en) 2001-07-19
BRPI0107493B8 (pt) 2021-05-25
CN1395484A (zh) 2003-02-05
BRPI0107493B1 (pt) 2019-04-16
ES2210120T3 (es) 2004-07-01

Similar Documents

Publication Publication Date Title
DE60124302D1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
ATE275145T1 (de) Chinazolinderivate zur behandlung von tumoren
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
ATE254913T1 (de) Diacerein zur behandlung von psoriasis
ATE250605T1 (de) Piperidin verbindung zur behandlung von psoriasis
DE60025369D1 (de) Unterchlorige säure enthaltendes superoxidiertes wasser zur behandlung von wunden
DE60114580D1 (de) Verwendung von cyanochinolinen zur behandlung oder inhibierung von dickdarmpolypen
DE60031710D1 (de) Fettsäurederivat zur behandlung von externen sekretionsstörungen
ATE265860T1 (de) Impstoff zur behandlung von atherosclerosis
DE60019158D1 (de) Neue oxabispidin-verbindungen zur behandlung von herzarrhythmien
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
DE60136477D1 (de) Retinoide zur behandlung von emphysem
DE50212701D1 (de) Bestrahlungsanordnung zur behandlung von akne und aknenarben
DE10082139T1 (de) Zusammensetzung zur Behandlung von Reibungspaaren
ATE279386T1 (de) Retinoide zur behandlung von emphysem
DE60123238D1 (de) Zusammensetzungen zur behandlung von autoimmunkrankheiten
DE60030554D1 (de) Verwendungen von et743 zur behandlung von krebs
DE60130661D1 (de) Verwendung der 13-cis retinsäure zur behandlung von emphysemen
DE60035326D1 (de) Verfahren zur Behandlung von Abwasser
DE50105735D1 (de) Chlorzoxazon zur behandlung von psoriasis
DE60238765D1 (de) Carbamatverbindungen zur behandlung von schmerz
ATE273276T1 (de) Cyclobutendion-derivate zur behandlung von artherosclerose
DE60026644D1 (de) Verwendung von Ferulasäure zur Behandlung von Bluthochdruck
DE60021252D1 (de) Antikonvulsiva zur behandlung von autismus
DE60001255D1 (de) Zusammensetzung zur Behandlung von Polyesterfaser

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1248608

Country of ref document: EP